Cargando…

β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice

INTRODUCTION: Vascular dementia is the second most common cause of dementia after Alzheimer’s disease (AD). In addition, it is estimated that almost half of all AD patients have significant cerebrovascular disease comorbid with their AD pathology. We hypothesized that cerebrovascular disease signifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sudduth, Tiffany L, Weekman, Erica M, Brothers, Holly M, Braun, Kaitlyn, Wilcock, Donna M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078260/ https://www.ncbi.nlm.nih.gov/pubmed/24991237 http://dx.doi.org/10.1186/alzrt262

Ejemplares similares

Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice
por: Weekman, Erica M, et al.
Publicado: (2014)

Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice
por: Latta, Clare H, et al.
Publicado: (2015)

Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain
por: Weekman, Erica M., et al.
Publicado: (2017)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)

Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes
por: Weekman, Erica M., et al.
Publicado: (2023)

Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events
por: Weekman, Erica M., et al.
Publicado: (2019)

Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia
por: Price, Brittani R., et al.
Publicado: (2018)

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
por: Dickey, Chad A, et al.
Publicado: (2005)

Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue
por: Weekman, Erica M., et al.
Publicado: (2022)

Blood Flow Deficits and Cerebrovascular Changes in a Dietary Model of Hyperhomocysteinemia
por: Braun, David J., et al.
Publicado: (2019)

Intracranial Injection of AAV Expressing NEP but Not IDE Reduces Amyloid Pathology in APP+PS1 Transgenic Mice
por: Carty, Nikisha, et al.
Publicado: (2013)

Lithium Treatment of APPSwDI/NOS2−/− Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype
por: Sudduth, Tiffany L., et al.
Publicado: (2012)

Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
por: Wilcock, Donna M, et al.
Publicado: (2004)

Water exchange rate across the blood‐brain barrier is associated with CSF amyloid‐β 42 in healthy older adults
por: Gold, Brian T., et al.
Publicado: (2021)

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
por: Steffen, Johannes, et al.
Publicado: (2017)

Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention
por: Linton, Alexandria E., et al.
Publicado: (2021)

Mechanisms of ARIA: is it time to focus on the unique immune environment of the neurovascular unit?
por: Foley, Kate E., et al.
Publicado: (2023)

Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice
por: Li, Bin, et al.
Publicado: (2011)

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease
por: Klakotskaia, Diana, et al.
Publicado: (2018)

Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice
por: Carty, Niki C, et al.
Publicado: (2006)

Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice
por: Luo, Gang, et al.
Publicado: (2016)

Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury
por: Long, Yanjun, et al.
Publicado: (2017)

Expression of complement system components during aging and amyloid deposition in APP transgenic mice
por: Reichwald, Julia, et al.
Publicado: (2009)

Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia
por: Braun, David J., et al.
Publicado: (2019)

VIP Enhances Phagocytosis of Fibrillar Beta-Amyloid by Microglia and Attenuates Amyloid Deposition in the Brain of APP/PS1 Mice
por: Song, Min, et al.
Publicado: (2012)

Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease
por: Braun, David J., et al.
Publicado: (2020)

Mechanism of arterial injury exacerbated by hyperhomocysteinemia in spontaneously hypertensive rats
por: Zhang, Lihua, et al.
Publicado: (2023)

Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice
por: Killick, Richard, et al.
Publicado: (2009)

Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)

SRC-1 Knockout Exerts No Effect on Amyloid β Deposition in APP/PS1 Mice
por: Wu, Qiong, et al.
Publicado: (2020)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
por: Yang, Xiao-bo, et al.
Publicado: (2022)

Autophagic Degradation Deficit Involved in Sevoflurane-Induced Amyloid Pathology and Spatial Learning Impairment in APP/PS1 Transgenic Mice
por: Geng, Pengcheng, et al.
Publicado: (2018)

Estrogen deficiency exacerbates learning and memory deficits associated with glucose metabolism disorder in APP/PS1 double transgenic female mice
por: Luo, Min, et al.
Publicado: (2021)

Hyperhomocysteinemia exacerbates acute kidney injury via increased mitochondrial damage
por: Zhang, Mei, et al.
Publicado: (2022)

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Iván, et al.
Publicado: (2013)

Immunocytochemical Characterization of Alzheimer’s Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Ivan, et al.
Publicado: (2014)

Cyclic Glycine-Proline Improves Memory and Reduces Amyloid Plaque Load in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease
por: Arora, Tushar, et al.
Publicado: (2023)

Humulus lupulus L. Extract Protects against Senior Osteoporosis through Inhibiting Amyloid β Deposition and Oxidative Stress in APP/PS1 Mutated Transgenic Mice and Osteoblasts
por: Xia, Tianshuang, et al.
Publicado: (2023)

ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
por: Button, Emily B., et al.
Publicado: (2019)

Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice
por: Chen, Lizhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fihmn11pob4etfliqs3odi6pm6